SURG.VSURG.VTSXV
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -130.83% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -135.57% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -133.33% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -133.33% | +0.00% |
| Weighted Average Shares Growth | +45.89% | +84.43% | +18.12% | +12.96% | +13.29% |
| Weighted Average Shares Diluted Growth | +45.89% | +33.17% | +18.12% | +12.96% | +13.29% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +111.78% | +1186.90% | +293.51% | +23.77% | +63.51% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +14.79% | +11.06% | -2.64% | +16.58% | +15.07% |
| Book Value per Share Growth | -19.79% | -38.75% | -16.05% | +2.27% | -0.09% |
| Debt Growth | -32.90% | -35.75% | -39.26% | -43.53% | -52.48% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -16.02% | +21.81% | +0.21% | -17.34% | +178.41% |